Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education Health and Sport · 2026-05-06Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-04-30SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30Raman Activity Investigation and Utilization of PsilocybinJournal of Raman Spectroscopy · 2026-03-18Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-24Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and PsilocybinHuman Psychopharmacology Clinical and Experimental · 2025-12-31Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyUnknown journal · 2025-11-30Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Unknown journal · 2025-10-30Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Unknown journal · 2025-10-22Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-08-31Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-17FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Unknown journal · 2025-04-21Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de ArgentinaBoletín de la Sociedad Argentina de Botánica · 2025-03-31A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.Unknown journal · 2025-03-16A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-14Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.Unknown journal · 2025-01-22Social pain: A systematic review on interventions.Unknown journal · 2025-01-09Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expressionbioRxiv · 2025-01-03Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.Unknown journal · 2024-12-09Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius haematocephalusBrazilian Journal of Science · 2024-10-31Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-08Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-09-19[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].Unknown journal · 2024-08-27THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility studyPsyArXiv · 2023-10-10Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?Psychedelic Medicine · 2023-08-17Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyJournal of Palliative Medicine · 2023-08-16Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndromePsychopharmacology · 2022-12-04Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis).Journal of Fungi · 2022-06-01Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-07Natural language signatures of psilocybin microdosingbioRxiv · 2022-02-21Psilocybin for the Treatment of Obsessive-Compulsive Disorders.Unknown journal · 2021-12-31P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of Clinical Psychopharmacology · 2021-04-30Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean Psychiatry · 2021-03-31Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.Unknown journal · 2019-04-25Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of Affective Disorders · 2018-03-31The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.Unknown journal · 2017-11-19Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.Unknown journal · 2016-10-30Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.Unknown journal · 2016-03-17The hallucinogenic world of tryptamines: an updated review.Unknown journal · 2015-04-15The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PLoS ONE · 2015-02-17Recreational use, analysis and toxicity of tryptamines.Unknown journal · 2014-12-31Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15Homological scaffolds of brain functional networks.Journal of The Royal Society Interface · 2014-11-30Magic truffles or Philosopher's stones: a legal way to sell psilocybin?Drug Testing and Analysis · 2012-08-08The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and PsilocybinLiving World, Journal of the Trinidad and Tobago Field Naturalists' Club · 2007-12-30Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of Clinical Psychiatry · 2006-10-31Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes.Unknown journal · 1994-06-30